Search and Browse
Download
Enter Data
| Reaction Details | |||
|---|---|---|---|
 | Report a problem with these data | ||
| Target | Insulin-like growth factor 1 receptor | ||
| Ligand | BDBM50296352 | ||
| Substrate/Competitor | n/a | ||
| Meas. Tech. | ChEMBL_581978 (CHEMBL1058958) | ||
| IC50 | 19±n/a nM | ||
| Citation |  Li, R; Pourpak, A; Morris, SW Inhibition of the insulin-like growth factor-1 receptor (IGF1R) tyrosine kinase as a novel cancer therapy approach. J Med Chem52:4981-5004 (2010) [PubMed] Article | ||
| More Info.: | Get all data from this article, Assay Method | ||
| Insulin-like growth factor 1 receptor | |||
| Name: | Insulin-like growth factor 1 receptor | ||
| Synonyms: | CD_antigen=CD221 | IGF-I receptor | IGF1R | IGF1R_HUMAN | Insulin-like growth factor 1 receptor (IGF1R) | Insulin-like growth factor 1 receptor (IGFIR) | Insulin-like growth factor 1 receptor alpha chain | Insulin-like growth factor 1 receptor beta chain | Insulin-like growth factor I receptor | Insulin-like growth factor receptor (IGFR) | ||
| Type: | Protein | ||
| Mol. Mass.: | 154776.79 | ||
| Organism: | Homo sapiens (Human) | ||
| Description: | P08069 | ||
| Residue: | 1367 | ||
| Sequence: |
| ||
| BDBM50296352 | |||
| n/a | |||
| Name | BDBM50296352 | ||
| Synonyms: | 1-(8-(3-(4-methylpiperazin-1-yl)cyclobutyl)-2-phenylquinolin-7-yl)imidazo[1,5-a]pyrazin-8-amine | CHEMBL551263 | ||
| Type | Small organic molecule | ||
| Emp. Form. | C30H31N7 | ||
| Mol. Mass. | 489.614 | ||
| SMILES | CN1CCN(CC1)C1CC(C1)c1c(ccc2ccc(nc12)-c1ccccc1)-c1ncn2ccnc(N)c12 |(21.77,-8.21,;20.98,-6.88,;19.44,-6.89,;18.66,-5.58,;19.42,-4.23,;20.96,-4.21,;21.74,-5.54,;18.63,-2.91,;17.14,-2.53,;17.52,-1.04,;19.01,-1.42,;16.74,.28,;15.2,.27,;14.4,1.57,;15.14,2.92,;16.69,2.95,;17.44,4.3,;18.98,4.33,;19.78,2.99,;19.03,1.64,;17.48,1.62,;21.32,3.02,;22.11,1.69,;23.65,1.72,;24.4,3.06,;23.6,4.39,;22.06,4.36,;14.45,-1.08,;15.1,-2.47,;13.98,-3.52,;12.64,-2.77,;11.19,-3.27,;10.03,-2.27,;10.32,-.76,;11.78,-.25,;12.07,1.26,;12.93,-1.27,)| | ||
| Structure | 
| ||